H. Mejia‐Santana

发表

Olfaction in Parkin heterozygotes and compound heterozygotes

K. Marder, M. Rezak, L. Cote, 2010, Neurology.

Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes.

H. Ostrer, V. Vacic, H. Hakonarson, 2014, Human molecular genetics.

The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD study

J. Nutt, K. Marder, M. Rezak, 2015, Movement disorders : official journal of the Movement Disorder Society.

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants

E. Tolosa, K. Marder, C. Tanner, 2014, Genetics in Medicine.

REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers

K. Marder, A. Mirelman, Nir Giladi, 2015, Movement disorders : official journal of the Movement Disorder Society.

Accuracy of family history data on Parkinson’s disease

E D Louis, S Fahn, R Ottman, 2003, Neurology.

Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant

K. Marder, A. Mirelman, Nir Giladi, 2022, Neurology.

Analysis of an early‐onset Parkinson's disease cohort for DJ‐1 mutations

A. Singleton, J. Hardy, K. Marder, 2004, Movement disorders : official journal of the Movement Disorder Society.

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study.

K. Marder, M. Rezak, L. Cote, 2010, Archives of neurology.

Cognitive performance of GBA mutation carriers with early-onset PD

K. Marder, M. Rezak, L. Cote, 2012, Neurology.

Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry

E. Tolosa, K. Marder, A. Mirelman, 2017, Movement disorders : official journal of the Movement Disorder Society.

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease

K. Marder, L. Cote, E. Karlins, 2006, Neurology.

Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease

K. Marder, L. Cote, S. Fahn, 2007, Neurology.

Familial aggregation of early‐ and late‐onset Parkinson's disease

Karen Marder, Stanley Fahn, Howard Andrews, 2003, Annals of neurology.

Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium

K. Marder, A. Mirelman, Nir Giladi, 2015, Neurology.

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

K. Marder, M. Rezak, L. Cote, 2010, Archives of neurology.

Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.

Karen Marder, Stanley Fahn, Daniel Rabinowitz, 2008, Archives of neurology.

Case-control study of the parkin gene in early-onset Parkinson disease.

K. Marder, L. Cote, E. Karlins, 2006, Archives of neurology.

Lack of familial aggregation of Parkinson disease and Alzheimer disease.

K. Marder, L. Cote, S. Fahn, 2004, Archives of neurology.

Increased rate of sporadic and recurrent rare genic copy number variants in Parkinson's disease among Ashkenazi Jews

K. Marder, L. Cote, S. Fahn, 2013, Molecular genetics & genomic medicine.

The association between Mediterranean diet adherence and Parkinson's disease

Nikolaos Scarmeas, K. Marder, L. Cote, 2012, Movement disorders : official journal of the Movement Disorder Society.

Application of the Movement Disorder Society prodromal criteria in healthy G2019S‐LRRK2 carriers

K. Marder, A. Mirelman, Nir Giladi, 2018, Movement disorders : official journal of the Movement Disorder Society.

Progression in the LRRK2-Asssociated Parkinson Disease Population

K. Marder, A. Mirelman, Nir Giladi, 2018, JAMA neurology.

Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls

E. Tolosa, K. Marder, A. Mirelman, 2019, Movement disorders : official journal of the Movement Disorder Society.

The Saitohin ‘Q7R’ polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts

K. Marder, B. Tycko, R. Mayeux, 2003, Neuroscience Letters.

Genetic and Clinical Predictors of Deep Brain Stimulation in Young‐Onset Parkinson's Disease

K. Marder, C. Goetz, L. Clark, 2016, Movement disorders clinical practice.

Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients☆☆☆

K. Marder, A. Mirelman, Nir Giladi, 2020, Clinical parkinsonism & related disorders.

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.

K. Marder, M. Rezak, L. Cote, 2009, Archives of neurology.

Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease

James E. Tomkins, B. Alipanahi, J. Trojanowski, 2021, Annals of neurology.

Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.

K. Marder, A. Mirelman, Nir Giladi, 2014, Parkinsonism & related disorders.

Genome-wide association studies of LRRK2 modifiers of Parkinson's disease

James E. Tomkins, B. Alipanahi, J. Trojanowski, 2020, medRxiv.

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.

J. Nutt, K. Marder, M. Rezak, 2014, JAMA neurology.

Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study

K. Marder, M. Rezak, L. Cote, 2010, Journal of the International Neuropsychological Society.

Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease

K. Marder, M. Rezak, L. Cote, 2010, Journal of clinical and experimental neuropsychology.

Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?

K. Marder, A. Mirelman, Nir Giladi, 2014, Annals of clinical and translational neurology.

Association of glucocerebrosidase mutations with dementia with lewy bodies.

K. Marder, R. Mayeux, L. Cote, 2009, Archives of neurology.

Pilot association study of the β‐glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity

K. Marder, R. Mayeux, L. Cote, 2005, Movement disorders : official journal of the Movement Disorder Society.

Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene

K. Marder, L. Cote, W. Scott, 2007, Movement disorders : official journal of the Movement Disorder Society.

Contribution of aging to the severity of different motor signs in Parkinson disease.

K. Marder, L. Cote, S. Fahn, 2005, Archives of neurology.

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene

K. Marder, A. Mirelman, Nir Giladi, 2015, Movement disorders : official journal of the Movement Disorder Society.

Age Specific Penetrance of the LRRK2 G2019S Mutation in the Michael J Fox Ashkenazi Jewish (AJ) LRRK2 Consortium (S17.002)

K. Marder, A. Mirelman, Nir Giladi, 2014 .

Interest in Genetic Testing in Ashkenazi Jewish Parkinson’s Disease Patients and Their Unaffected Relatives

K. Marder, A. Mirelman, Nir Giladi, 2015, Journal of Genetic Counseling.

Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD

K. Marder, L. Cote, S. Fahn, 2003, Neurology.

Body mass index in essential tremor.

K. Marder, G. Levy, E. Louis, 2002, Archives of neurology.

The relation between depression and parkin genotype: the CORE-PD study.

K. Marder, M. Rezak, L. Cote, 2011, Parkinsonism & related disorders.

Estimation of genetic risk function with covariates in the presence of missing genotypes

K. Marder, Nir Giladi, S. Bressman, 2017, Statistics in medicine.

Analysis of an early‐onset Parkinson's disease cohort for DJ‐1 mutations

A. Singleton, K. Marder, R. Mayeux, 2004, Movement disorders : official journal of the Movement Disorder Society.

Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.

K. Marder, A. Mirelman, Nir Giladi, 2015, Parkinsonism & related disorders.

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.

K. Marder, M. Rezak, L. Cote, 2009, Archives of neurology.

Motor Phenotype of Lrrk2 G2019s Carriers in Early Onset Parkinson Disease Statistical Analyses Were Conducted Nih Public Access Author Manuscript

M. Verbitsky, R. Alcalay, H. Mejia‐Santana, 2022 .

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study.

K. Marder, M. Rezak, L. Cote, 2010, Archives of neurology.

Evidence for increased completed suicide in first-degree relatives of LRRK2 G2019S mutation Parkinson’s disease

K. Marder, A. Mirelman, Nir Giladi, 2018, Journal of Neurology Neurosurgery & Psychiatry.